Since continuous infusion allows the stable presence of circulating FGF21 levels throughout the course of the study, it is particularly suitable for studying the long-term effects of FGF21 (such as mimicking the overall increased FGF21 levels in metabolic diseases or testing the chronic therapeutic efficacy of FGF21). Here, FGF21 is linked to Other metabolic disease.